Bright Cell Inc is an Irvine-California based biotechnology company specializing both in banking mesenchymal stem cell (MSC) from umbilical cord tissue of newborn babies and manufacturing clinical grades human Umbilical Cord-MSC (hUC-MSC) from the unlimited sources tissues that are traditionally regarded as medical waste. We embrace the advantages of hUC-MSC over MSC derived from other adult tissues including non-invasive procedure to the donor, robust proliferation, high ex vivo scalability and superior biological activities, etc. We also possess proprietary technologies to modify the hUC-MSC by chemical or genetic means to extend their therapeutic profile.

“Bright Cell is proud to be one of the few sponsors of the FDA regulated clinical trials with Umbilical cord Mesenchymal Stem cell (MSC) and making all effort to be the First pharmaceutical company to launch the FDA approved drug”